Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas

Semin Oncol. 1994 Dec;21(6 Suppl 16):25-8.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Chemotherapy, Adjuvant
  • Cyclophosphamide / administration & dosage
  • Disease-Free Survival
  • Doxorubicin / administration & dosage
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / therapy
  • Middle Aged
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Remission Induction
  • Vincristine / administration & dosage

Substances

  • Recombinant Proteins
  • Bleomycin
  • Procarbazine
  • Vincristine
  • Doxorubicin
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • COP-BLAM protocol